Member Exclusive NEWS ROUND-UP

Cell therapy weekly: Results of breakthrough trial for cell-based stroke therapy revealed

This week: An international marketing license for a mesenchymal stem cell (MSC)-based product for the prevention and treatment of graft-versus-host disease (GvHD), and a new technology that de-risks clinical trial and commercial shipments.

Go to the profile of RegMedNet
Sep 19, 2019

Please sign in or register for FREE

No comments yet.